Litcius/Paper detail

Targeting CD47/SIRPα in Acute Myeloid Leukemia and Myelodysplastic Syndrome: Preclinical and Clinical Developments of Magrolimab

Fadi Haddad, Naval Daver

2021Journal of Immunotherapy and Precision Oncology31 citationsDOIOpen Access PDF

Topics & Concepts

Myeloid leukemiaCD47Myelodysplastic syndromesMedicineMyeloidCancer researchImmunologyBone marrowAntibodyPhagocytosis and Immune RegulationImmune cells in cancerErythrocyte Function and Pathophysiology
Targeting CD47/SIRPα in Acute Myeloid Leukemia and Myelodysplastic Syndrome: Preclinical and Clinical Developments of Magrolimab | Litcius